Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

B7-1 and B7-2 are generally thought to have comparable structures and affinities for their receptors, CD28 and CTLA-4, each of which is assumed to be bivalent. We show instead (1) that B7-2 binds the two receptors more weakly than B7-1, (2) that, relative to its CTLA-4 binding affinity, B7-2 binds CD28 2- to 3-fold more effectively than B7-1, (3) that, unlike B7-1, B7-2 does not self-associate, and (4) that, in contrast to CTLA-4 homodimers, which are bivalent, CD28 homodimers are monovalent. Our results indicate that B7-1 markedly favors CTLA-4 over CD28 engagement, whereas B7-2 exhibits much less bias. We propose that the distinct structures and binding properties of B7-1 and B7-2 account for their overlapping but distinct effects on T cell responses.

Original publication

DOI

10.1016/s1074-7613(02)00362-x

Type

Journal article

Journal

Immunity

Publication Date

08/2002

Volume

17

Pages

201 - 210

Keywords

Abatacept, Animals, Antigens, CD, Antigens, Differentiation, B7-1 Antigen, B7-2 Antigen, CD28 Antigens, CHO Cells, CTLA-4 Antigen, Cricetinae, Immunoconjugates, Kinetics, Membrane Glycoproteins, Protein Structure, Tertiary, Recombinant Fusion Proteins, Solutions